Neogen | NEOG - Operating Profit


Neogen reported $-5.38M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Agilent USD 443M 66M Sep/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Cerus USD -1.45M 488K Dec/2024
Danaher USD 1.5B 348M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Illumina USD 256M 6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
OraSure Technologies USD -6M 3.26M Sep/2024
Pacific Biosciences Of California USD -64.08M 111.77M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD 18.49M 43.21M Sep/2025
Surmodics USD -5.64M 276K Sep/2024
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Utah Medical Products USD 3.76M 310K Sep/2024
Zoetis USD 835M 101M Dec/2025